MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells. [electronic resource]
Producer: 20200402Description: e0223225 p. digitalISSN:- 1932-6203
- Afatinib -- pharmacology
- Cell Line, Tumor
- Cell Movement -- genetics
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Gene Knockdown Techniques
- Humans
- Intravital Microscopy
- Microscopy, Fluorescence
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-met -- genetics
- RNA, Small Interfering -- metabolism
- Stomach Neoplasms -- drug therapy
- Time-Lapse Imaging
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.